Search Results

Filter
  • 1-10 of  3,219 results for ""Antigens, Surface""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin.

  • Authors : Kuzmanov A; Department of Urology, University Hospital Zürich, University of Zurich, Laboratory for Urologic Oncology and Stem Cell Therapy, Zurich, Switzerland.; Salemi S

Subjects: Dutasteride*/Dutasteride*/Dutasteride*/pharmacology ; Dutasteride*/Dutasteride*/Dutasteride*/therapeutic use ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Nov; Vol. 57, pp. 101045. Date of Electronic Publication: 2024 Sep 05.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen.

  • Authors : Lewis MR; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, United States of America; Molecular Imaging and Theranostics Center, University of Missouri, Columbia, MO, United States of America

Subjects: Copper Radioisotopes* ; Antigens, Surface*/Antigens, Surface*/Antigens, Surface*/metabolism ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism

  • Source: Nuclear medicine and biology [Nucl Med Biol] 2024 Sep-Oct; Vol. 136-137, pp. 108938. Date of Electronic Publication: 2024 Jul 14.Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism

  • Source: Nuclear medicine and biology [Nucl Med Biol] 2024 Jul-Aug; Vol. 134-135, pp. 108913. Date of Electronic Publication: 2024 Apr 25.Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.

  • Authors : Muniz M; Department of Medical Oncology, Mayo Clinic, Rochester, MN, US. Electronic address: .; Loprinzi CL

Subjects: Radiopharmaceuticals*/Radiopharmaceuticals*/Radiopharmaceuticals*/therapeutic use ; Antigens, Surface* ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/antagonists & inhibitors

  • Source: Cancer treatment reviews [Cancer Treat Rev] 2024 Jun; Vol. 127, pp. 102748. Date of Electronic Publication: 2024 Apr 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

The co-expression of antigen targets as a rationale for ADC combination in urothelial cancer.

  • Authors : Bertucci F; Predictive Oncology Laboratory, Marseille Cancer Research Center (CRCM), Aix-Marseille University, U1068 INSERM, U7258 CNRS, Institut Paoli-Calmettes, Marseille; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: .

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/immunology

  • Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 May; Vol. 35 (5), pp. 477-478. Date of Electronic Publication: 2024 Feb 14.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

45 Ti targeted tracers for PET imaging of PSMA.

  • Authors : Chaple IF; Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: .; Houson HA

Subjects: Antigens, Surface*/Antigens, Surface*/Antigens, Surface*/metabolism ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging

  • Source: Nuclear medicine and biology [Nucl Med Biol] 2022 May-Jun; Vol. 108-109, pp. 16-23. Date of Electronic Publication: 2022 Feb 04.Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy.

  • Authors : Wenzel M; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.

Subjects: Antigens, Surface* ; Glutamate Carboxypeptidase II* ; Positron Emission Tomography Computed Tomography*/Positron Emission Tomography Computed Tomography*/Positron Emission Tomography Computed Tomography*/methods

  • Source: Urologic oncology [Urol Oncol] 2022 Jan; Vol. 40 (1), pp. 7.e1-7.e8. Date of Electronic Publication: 2021 Jul 31.Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.

  • Authors : Zeng Z; The Medical College of Qingdao University, Qingdao, 266071, China; The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, China.

Subjects: Antigens, Surface/Antigens, Surface/Antigens, Surface/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Aug 20; Vol. 566, pp. 80-86. Date of Electronic Publication: 2021 Jun 10.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far.

  • Authors : Heynickx N; Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium; Department of Molecular Biotechnology, Ghent University, Ghent, Belgium.

Subjects: Salivary Glands*/Salivary Glands*/Salivary Glands*/radiation effects ; Salivary Glands*/Salivary Glands*/Salivary Glands*/metabolism ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism

  • Source: Nuclear medicine and biology [Nucl Med Biol] 2021 Jul-Aug; Vol. 98-99, pp. 30-39. Date of Electronic Publication: 2021 May 08.Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.

  • Authors : Nikfarjam Z; Department of Physical & Computational Chemistry, Chemistry and Chemical Engineering Research Center of Iran, Tehran, 1496813151, Iran.; Bavi O

Subjects: Antigens, Surface/Antigens, Surface/Antigens, Surface/*metabolism ; Enzyme Inhibitors/Enzyme Inhibitors/Enzyme Inhibitors/*metabolism ; Glutamate Carboxypeptidase II/Glutamate Carboxypeptidase II/Glutamate Carboxypeptidase II/*metabolism

  • Source: Archives of biochemistry and biophysics [Arch Biochem Biophys] 2021 Mar 15; Vol. 699, pp. 108747. Date of Electronic Publication: 2021 Jan 07.Publisher: Elsevier Country of Publication: United States NLM ID: 0372430 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  3,219 results for ""Antigens, Surface""